A nationwide cohort study examines the oncologic safety of GLP-1 receptor agonists in patients with endogenous Cushing syndrome.
Sleeve gastrectomy may offer greater weight loss and glycemic control than semaglutide or tirzepatide in adults with obesity and T2D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results